Reported about 5 hours ago
Johnson & Johnson (NYSE: JNJ) is a leading healthcare company with a reliable business model, but it has faced legal challenges and slower revenue growth in recent years. Despite these obstacles, the company’s strong balance sheet and dividend history indicate stability, making it a potential long-term choice for income-seeking investors. Johnson & Johnson is also pursuing growth opportunities in innovative fields, particularly robotic-assisted surgery, which could bolster its prospects. While investors should remain vigilant about ongoing issues, the stock may appeal to those prioritizing steady returns over high growth.
Source: YAHOO